(Q34276988)

1 August 2017

1 reference

title

Mutations in apoptosis genes: a pathogenetic factor for human disease (English)

1 reference

1 August 2017

0 references

1 reference

Müllauer L

1

1 reference

1 August 2017

Gruber P

2

1 reference

1 August 2017

Sebinger D

3

1 reference

1 August 2017

Buch J

4

1 reference

1 August 2017

Wohlfart S

5

1 reference

1 August 2017

Chott A

6

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

1 August 2017

1 reference

1 August 2017

488

1 reference

1 August 2017

211-231

1 reference

1 August 2017

3

1 reference

A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Death receptors: signaling and modulation

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Apoptotic pathways: the roads to ruin

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Cell Death in Development

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Modulation of life and death by the TNF receptor superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Fas ligand-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Fas ligand, death gene.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

TRAIL: a molecule with multiple receptors and control mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Caspases: enemies within

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Mechanisms mediating caspase activation in cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Serial killers: ordering caspase activation events in apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Mitochondria and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Apoptosis: checkpoint at the mitochondrial frontier.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Mitochondrial control of cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

The Bcl-2 protein family: arbiters of cell survival

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Bcl-2 family proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

BCL-2 family members and the mitochondria in apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Bcl-2 family proteins as ion-channels

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

p53, the cellular gatekeeper for growth and division

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

The cellular response to p53: the decision between life and death

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Requirement for p53 and p21 to sustain G2 arrest after DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

A model for p53-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Apoptosis in human disease: a new skin for the old ceremony?

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Role of active cell death (apoptosis) in multi-stage carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Apoptosis in human autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

The role of apoptosis in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Alterations of Fas (Apo-1/CD95) gene in cutaneous malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Frameshift mutations in Fas, Apaf-1 and Bcl-10 in gastro-intestinal cancer of the microsatellite mutator phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32)

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

The apoptotic regulatory gene, BCL10, is mutated in sporadic mismatch repair deficient colorectal cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Preferential linkage of bcl-2 to immunoglobulin light chain gene in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

The product of the t(11;18), an API2-MLT fusion, marks nearly half of gastric MALT type lymphomas without large cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Autoimmune lymphoproliferative syndrome, a disorder of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

The hereditary periodic fever syndromes: molecular analysis of a new family of inflammatory diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Linkage of familial hemophagocytic lymphohistiocytosis to 10q21-22 and evidence for heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Perforin gene defects in familial hemophagocytic lymphohistiocytosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Spinal muscular atrophy: molecular pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

RAIDD is a new 'death' adaptor molecule

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Two CD95 (APO-1/Fas) signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

The peripheral deletion of autoreactive CD8+ T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, Apo-1).

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Fas and Fas ligand: lpr and gld mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Clinical effects of mutations to CD95 (Fas): relevance to autoimmunity?

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Somatic mutation of the CD95 gene in human B cells as a side-effect of the germinal center reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

In vivo expression of soluble Fas and FAP-1: possible mechanisms of Fas resistance in human hepatoblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Mutation analysis of CD95 (APO-1/Fas) in childhood B-lineage acute lymphoblastic leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Fas counter-attack–the best form of tumor defense?

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

The role of placental Fas ligand in maintaining immune privilege at maternal-fetal interfaces

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Lymphocyte granule-mediated apoptosis: matters of viral mimicry and deadly proteases

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Granzyme B mimics apical caspases. Description of a unified pathway for trans-activation of executioner caspase-3 and -7.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Defective natural killer cell function in patients with hemophagocytic lymphohistiocytosis and in first degree relatives

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Fas-associated death domain protein interleukin-1beta-converting enzyme 2 (FLICE2), an ICE/Ced-3 homologue, is proximally involved in CD95- and p55-mediated death signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

TRAIL (Apo2 ligand) and TWEAK (Apo3 ligand) mediate CD4+ T cell killing of antigen-presenting macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

mE10, a novel caspase recruitment domain-containing proapoptotic molecule

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

CLAP, a novel caspase recruitment domain-containing protein in the tumor necrosis factor receptor pathway, regulates NF-kappaB activation and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

The CARD domain: a new apoptotic signalling motif

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Regulatory mechanisms of TRAF2-mediated signal transduction by Bcl10, a MALT lymphoma-associated protein

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Inhibition of TNF-induced apoptosis by NF-kappa B.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

The NF-kappaB/Rel family of transcription factors in oncogenic transformation and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

NF-kappaB inhibits apoptosis in murine mammary epithelia

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Progress in understanding the mechanism and consequences of somatic hypermutation

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Infrequent BCL10 mutations in B-cell non-Hodgkin's lymphomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Analysis of BCL-10 gene mutations in ovarian cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Lack of BCL10 mutations in germ cell tumors and B cell lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Absence of BCL10 mutations in human malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Bcl10 is not a target for frequent mutation in human carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

BCL10 gene mutations rarely occur in lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Mutations in RNA: a first example of molecular misreading in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

The complexity of p53 modulation: emerging patterns from divergent signals

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Regulation and activation of p53 and its family members

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Role of NF-κB in p53-mediated programmed cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Li-Fraumeni syndrome--a molecular and clinical review

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Bax-deficient mice with lymphoid hyperplasia and male germ cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Bax suppresses tumorigenesis and stimulates apoptosis in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Genetics of colonic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Mutational analysis of Bax and Bcl-2 in childhood acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

An exegesis of IAPs: salvation and surprises from BIR motifs

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

The iap genes: unique arbitrators of cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

IAP family proteins--suppressors of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

The inhibitors of apoptosis (IAPs) and their emerging role in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Exclusive detection of the t(11;18)(q21;q21) in extranodal marginal zone B cell lymphomas (MZBL) of MALT type in contrast to other MZBL and extranodal large B cell lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Neuroprotection by the inhibition of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

The hippocampal neurons of neuronal apoptosis inhibitory protein 1 (NAIP1)-deleted mice display increased vulnerability to kainic acid-induced injury

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

The role of the SMN gene in proximal spinal muscular atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Synergistic anti-apoptotic activity between Bcl-2 and SMN implicated in spinal muscular atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Identification of a candidate modifying gene for spinal muscular atrophy by comparative genomics

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Reduced survival motor neuron (Smn) gene dose in mice leads to motor neuron degeneration: an animal model for spinal muscular atrophy type III

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Detection and relevance of minimal disease in lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Activation of the CD95 (APO-1/Fas) pathway in drug- and gamma-irradiation-induced apoptosis of brain tumor cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Activation of apoptosis pathways by anticancer treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Ionizing radiation and chemotherapeutic drugs induce apoptosis in lymphocytes in the absence of Fas or FADD/MORT1 signaling. Implications for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Oncogenic aberrations in the p53 pathway are associated with a high S phase fraction and poor patient survival in B-cell Non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Tumor biology of mucosa-associated lymphoid tissue lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

From bench to clinic with apoptosis-based therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

A specific inhibitor of apoptosis decreases tissue injury after intestinal ischemia-reperfusion in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Caspase inhibition reduces apoptosis and increases survival of nigral transplants.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Caspase inhibition increases embryonic striatal graft survival

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Neuroprotection by a caspase inhibitor in acute bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Prevention of lymphocyte cell death in sepsis improves survival in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Peptidomimetic fluoromethylketone rescues mice from lethal endotoxic shock.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

p53-oriented cancer therapies: current progress

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Induction of wild-type p53 activity in human cancer cells by ribozymes that repair mutant p53 transcripts

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type. P53 (Ad-p53)

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Chemosensitisation of malignant melanoma by BCL2 antisense therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Phase I clinical and pharmacokinetic study of bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

Bcl-2 antisense oligonucleotides (G3139) inhibit Merkel cell carcinoma growth in SCID mice

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2801%2900057-6

7 January 2021

10.1016/S1383-5742(01)00057-6

Identifiers

DOI

1 reference

1 August 2017

1 reference